My understanding is that in a randomised trial, one aim of randomisation is to reduce the chance of baseline imbalances (i.e. possible confounding factors) between groups.
Obviously known confounders, such as age, sex or any other difference of which we are aware can be dealt with before randomisation with methods to ensure that they are distibuted randomly between intervention and control groups.
Possible unkown factors, however cannot, and so we rely and randomisation for this. It is well documented that randomisation cannot be sure to eliminate these (ref: Howick, The Philosopy of Evidence Based Medicine) however it is the better at reducing them than a non randomised study.
Howick claims that additionally, as study sizes increase, the law of large numbers will increase the likelihood that basline differences between the groups that could be confounding factors will remain. This seems to make sense to me.
However I seem to have found a paper http://www.ncbi.nlm.nih.gov/pubmed/2727470 that seems to suggest this is not true. You may not be able to access the whole thing, but the abstract staes that they conclude:
covariate imbalance is just as much a problem for large studies as for small ones in terms of effect on size
Am I correct in thinking that this is saying that larger studies do not deal with possible unkown confounding factors better than small ones?
If so, does anybody know why this might be the case, or any other papers on this issue? (I realise this might be difficult as you may not have access for the paper)
Just to put things in context I am coming from a philosophy of science position.